Application
Western blot analysis of ZNF268 Antibody (N-term) in A375 cell line lysates (35ug/lane). ZNF268 (arrow) was detected using the purified Pab.Application
ZNF268 Antibody (N-term) IHC analysis in formalin fixed and paraffin embedded skin carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ZNF268 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | ZNF268 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | ZNF268; Zinc finger protein 268; Zinc finger protein HZF3 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | ZNF268 Zinc finger protein 268 Zinc finger protein HZF3 |
|---|---|
| Molecular Weight(MW) | 108374 Da |
| Function | May be involved in transcriptional regulation. |
| Tissue Specificity | This ZNF268 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 39~69 amino acids from the N-terminal region of human ZNF268. |
| Cellular Localization | Nucleus (Probable). |
| Entrez Gene | 10795 |
|---|
Application
Western blot analysis of ZNF268 Antibody (N-term) in A375 cell line lysates (35ug/lane). ZNF268 (arrow) was detected using the purified Pab.
Application
ZNF268 Antibody (N-term) IHC analysis in formalin fixed and paraffin embedded skin carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the ZNF268 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
